✨
AI Summary
- Discussion on the non-alcoholic steatohepatitis (NASH) treatment market.
- Insights from Datamonitor Healthcare analyst Ken Hoang.
- Exploring current and future NASH therapies.
Guests on This Episode
KH
Ken Hoang
1 podcast appearance